Updated March 11, 2024: For added information, visit BC Government Your Voice page The province of BC is inviting input from the public coverage for Maviret ® (glecaprevir-pibrentasvir), a drug that can be used to treat hepatitis C in pediatric patients between the ages of 3 and 11. Taken in granule format, this drug is… Read more »
Call for public input for PharmaCare Drug Coverage review: Maviret®
Posted On: Monday, March 4th, 2024